Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam S Cheifetz

Showing results (101-110 of 203) with videos related to

Pageof 21
Sort By:
Scandinavian Journal of Gastroenterology|July 6, 2026
Assessing trial eligibility and real-world response to vedolizumab and ustekinumab in patients with ulcerative colitisStephen Le Breton, Aditya Mithal, Tasnim Ahmed, et al.
Journal of Digestive Diseases|November 10, 2017
C-reactive protein as a predictor of low trough infliximab concentrations in patients who lose response to infliximabMarie P Boyle, Alan C Moss, Aoibhlinn M O'Toole, et al.
Journal of Crohn'S & Colitis|March 29, 2018
Proactive Infliximab Monitoring Following Reactive Testing is Associated With Better Clinical Outcomes Than Reactive Testing Alone in Patients With Inflammatory Bowel DiseaseKonstantinos Papamichael, Ravy K Vajravelu, Byron P Vaughn, et al.
Inflammatory Bowel Diseases|September 29, 2011
Screening for tuberculosis and hepatitis B prior to the initiation of anti-tumor necrosis therapyByron P Vaughn, Glen A Doherty, Shiva Gautam, et al.
Inflammatory Bowel Diseases|August 28, 2015
Adherence to Rectal Mesalamine in Patients with Ulcerative ColitisMarie Boyle, Amanda Ting, Didia B Cury, et al.
Clinical Immunology (Orlando, Fla.)|March 17, 2018
Biological therapies in inflammatory bowel disease: Beyond anti-TNF therapiesKonstantinos H Katsanos, Konstantinos Papamichael, Joseph D Feuerstein, et al.
Inflammatory Bowel Diseases|April 19, 2020
A Survey Study of Gastroenterologists' Views on Dysplasia Surveillance and Chromoendoscopy in IBDLaurie B Grossberg, Francis A Farraye, Konstantinos Papamichael, et al.
Digestive Diseases and Sciences|June 18, 2009
Impact of concomitant immunomodulator use on long-term outcomes in patients receiving scheduled maintenance infliximabAlan C Moss, Kyung Jo Kim, Nielsen Fernandez-Becker, et al.
Gastro Hep Advances|November 18, 2024
Irritable Bowel Syndrome/Inflammatory Bowel Disease Overlap: Less Common Than We ThinkLauren K Burdine, Shana Rakowsky, Laurie Grossberg, et al.
Inflammatory Bowel Diseases|January 11, 2014
The burden of inflammatory bowel disease: a patient-reported qualitative analysis and development of a conceptual modelJennifer Devlen, Kathleen Beusterien, Linnette Yen, et al.
Pageof 21

Showing results (101-110 of 203) with videos related to

Sort By:
Pageof 21
Scandinavian Journal of Gastroenterology|July 6, 2026
Assessing trial eligibility and real-world response to vedolizumab and ustekinumab in patients with ulcerative colitisStephen Le Breton, Aditya Mithal, Tasnim Ahmed, et al.
Journal of Digestive Diseases|November 10, 2017
C-reactive protein as a predictor of low trough infliximab concentrations in patients who lose response to infliximabMarie P Boyle, Alan C Moss, Aoibhlinn M O'Toole, et al.
Journal of Crohn'S & Colitis|March 29, 2018
Proactive Infliximab Monitoring Following Reactive Testing is Associated With Better Clinical Outcomes Than Reactive Testing Alone in Patients With Inflammatory Bowel DiseaseKonstantinos Papamichael, Ravy K Vajravelu, Byron P Vaughn, et al.
Inflammatory Bowel Diseases|September 29, 2011
Screening for tuberculosis and hepatitis B prior to the initiation of anti-tumor necrosis therapyByron P Vaughn, Glen A Doherty, Shiva Gautam, et al.
Inflammatory Bowel Diseases|August 28, 2015
Adherence to Rectal Mesalamine in Patients with Ulcerative ColitisMarie Boyle, Amanda Ting, Didia B Cury, et al.
Clinical Immunology (Orlando, Fla.)|March 17, 2018
Biological therapies in inflammatory bowel disease: Beyond anti-TNF therapiesKonstantinos H Katsanos, Konstantinos Papamichael, Joseph D Feuerstein, et al.
Inflammatory Bowel Diseases|April 19, 2020
A Survey Study of Gastroenterologists' Views on Dysplasia Surveillance and Chromoendoscopy in IBDLaurie B Grossberg, Francis A Farraye, Konstantinos Papamichael, et al.
Digestive Diseases and Sciences|June 18, 2009
Impact of concomitant immunomodulator use on long-term outcomes in patients receiving scheduled maintenance infliximabAlan C Moss, Kyung Jo Kim, Nielsen Fernandez-Becker, et al.
Gastro Hep Advances|November 18, 2024
Irritable Bowel Syndrome/Inflammatory Bowel Disease Overlap: Less Common Than We ThinkLauren K Burdine, Shana Rakowsky, Laurie Grossberg, et al.
Inflammatory Bowel Diseases|January 11, 2014
The burden of inflammatory bowel disease: a patient-reported qualitative analysis and development of a conceptual modelJennifer Devlen, Kathleen Beusterien, Linnette Yen, et al.
Pageof 21